跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 62 条关于
“OmniVu”
全部
62
临床试验
37
药物
10
机构
6
资讯
9
去年
FDA Approves Clinical Trial of Atia Vision's Innovative OmniVu Lens System for Cataract Patients
去年
Atia Vision's OmniVu IOL Shows Promising 2-Year Results for Presbyopia and Cataract Treatment
3个月前
Omnix Medical Initiates Phase II Trial of OMN6 for Drug-Resistant Acinetobacter baumannii Infections
11个月前
Omnix Medical Raises $25 Million Series C to Advance Novel Antimicrobial Against Drug-Resistant Infections
前天
BlossomHill's OMNI-EGFR Inhibitor BH-30643 Yields 45% ORR in C797S-Positive NSCLC
去年
BlossomHill Therapeutics to Present Novel OMNI-EGFR Inhibitor BH-30643 at AACR 2025 for NSCLC Treatment
去年
BlossomHill Therapeutics Advances EGFR-Mutant NSCLC Treatment with First-in-Class OMNI-EGFR Inhibitor BH-30643
去年
OMNI® Surgical System Shows Long-Term Efficacy in Comprehensive 22-Study Meta-Analysis for Glaucoma Treatment
去年
Sight Sciences OMNI System Gains UnitedHealthcare Coverage as Meta-Analysis Confirms Long-Term Efficacy in Glaucoma Treatment